Polydimethylsiloxane (PDMS) as a Replacement Substrate for Live Cell Imaging and UV Microscopy

­

Application

Visualize cells and tissues utilizing UV microscopy.

Key Benefits

  • Low cost.
  • Quick diagnostic for blood cultures especially for cancer diagnosis or Sickle cell anemia.
  • Ability to visualize live cells and tissues via UV microscopy.
  • Label and fixative free.

Market Summary

Polydimethylsiloxane (PDMS) is a silicon-based organic polymer which is widely used in many industries for various applications including medical devices, cosmetics, lubrication, etc. PDMS is a versatile and low-cost polymer which possesses unique physical and chemical properties that makes it suitable for manufacturing PDMS-based devices and substrates. Apart from being non-toxic and inflammable, PDMS is optically clear and when manufactured into a microfluidic device can enable microscopic evaluation of many biological and physical phenomena under visible light. Despite these unique properties, the application of PDMS-based devices to study live cells under ultraviolet (UV) light via label and fixative-free UV microscopy has been largely neglected. PDMS is significantly less expensive than the conventional UV-transparent materials such as quartz or fused silica and can be readily manufactured in large quantities, making it a suitable alternative for many applications such as UV microscopy and spectroscopy of cells, tissues, and biomolecules for research and diagnostic purposes.

Technical Summary

Emory researchers have recently used deep UV microscopy for label free detection of blood components in UV transparent PDMS based microfluidic devices. Researchers first characterized the optical absorption properties of PDMS in the blue to UV-C regions of the spectrum (c.a. 450-220 nm) and demonstrated the utility of the PDMS substrate material for microscopy in this wavelength range. The low optical transmittance of plastics and glass in the UV range could then be circumvented using this method. With these results, they could then develop an array of microfluidic systems for easy, label free imaging of whole blood and detection of white blood cells. This reduces the need for costly and complex staining procedures, and signifies its unique implications in many areas of medicine and biology.

Patent Information

App Type Country Serial No. Patent No. File Date Issued Date Patent Status
Utility (parent) United States 18/063,531   12/8/2022   Pending
Tech ID: 21079
Published: 2/23/2022